Probiotics: is it Really That Good? Cost-Effectiveness of Treating the in-Patient

• Status: Unknown status
• Trial end date: 2008-07-01
• Target enrollment: 0
• Participant gender: All

Summary

Medical literature has dealt with various perspectives of probiotic therapy - prevention of antibiotic associated diarrhoea, Clostridium difficile, etc.

However, there have been no published results which can provide a basis for a generalized recommendation or discouragement of probiotic use among various groups of hospitalized patients.

The hypothesis is that the benefit in probiotic therapy in the admitted patient is by far larger than the actual cost of therapy. This assumption is probably true for all admitted patients and for patients on antibiotic therapy in particular.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Hadassah Medical Organization

Criteria

Inclusion Criteria:

• All patients hospitalized in the Department of Internal Medicine for a minimum duration of 3 days.

• Age (all >18) and gender are to have no impact on the usage of the drug.

Exclusion Criteria:

• patients who do not agree to participate in the study

• patients on an NPO (nothing per os) order, if NPO includes medications

• patients who suffer of Celiac disease